Literature DB >> 9286414

Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression. A role in the immune tolerance to antigenic tumors.

P Chaux1, N Favre, B Bonnotte, M Moutet, M Martin, F Martin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9286414     DOI： 10.1007/978-1-4757-9966-8_86

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  11 in total

1.  Tumours can act as adjuvants for humoral immunity.

Authors:  D M Brown; T L Fisher; C Wei; J G Frelinger; E M Lord
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

2.  Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesis associated with elevated levels of VEGF.

Authors:  Yuhui Huang; Xiaolan Chen; Mikhail M Dikov; Sergey V Novitskiy; Claudio A Mosse; Li Yang; David P Carbone
Journal:  Blood       Date:  2007-03-21       Impact factor: 22.113

3.  Immunization with dendritic cells pulsed with tumor extract increases survival of mice bearing intracranial gliomas.

Authors:  H T Ni; S R Spellman; W C Jean; W A Hall; W C Low
Journal:  J Neurooncol       Date:  2001-01       Impact factor: 4.130

Review 4.  Complex role for the immune system in initiation and progression of pancreatic cancer.

Authors:  Kristin S Inman; Amanda A Francis; Nicole R Murray
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

5.  Anti-CD40 antibody and toll-like receptor 3 ligand restore dendritic cell-mediated anti-tumor immunity suppressed by morphine.

Authors:  Ming-Cheng Chang; Yu-Li Chen; Ying-Cheng Chiang; Ya-Jung Cheng; Yu-Wei Jen; Chi-An Chen; Wen-Fang Cheng; Wei-Zen Sun
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

Review 6.  The dendritic cell-regulatory T lymphocyte crosstalk contributes to tumor-induced tolerance.

Authors:  Nona Janikashvili; Bernard Bonnotte; Emmanuel Katsanis; Nicolas Larmonier
Journal:  Clin Dev Immunol       Date:  2011-11-03

7.  The tumor microenvironment: a pitch for multiple players.

Authors:  Giovanna Schiavoni; Lucia Gabriele; Fabrizio Mattei
Journal:  Front Oncol       Date:  2013-04-17       Impact factor: 6.244

8.  Ex vivo recovery and activation of dysfunctional, anergic, monocyte-derived dendritic cells from patients with operable breast cancer: critical role of IFN-alpha.

Authors:  Sukchai Satthaporn; Mark M Aloysius; Richard A Robins; Chandan Verma; Suebwong Chuthapisith; Alasdair J McKechnie; Mohamad El-Sheemy; Wichai Vassanasiri; David Valerio; David Clark; Jibril A Jibril; Oleg Eremin
Journal:  BMC Immunol       Date:  2008-06-27       Impact factor: 3.615

9.  T Lymphocyte Inhibition by Tumor-Infiltrating Dendritic Cells Involves Ectonucleotidase CD39 but Not Arginase-1.

Authors:  Malika Trad; Alexandrine Gautheron; Jennifer Fraszczak; Darya Alizadeh; Claire Larmonier; Collin J LaCasse; Sara Centuori; Sylvain Audia; Maxime Samson; Marion Ciudad; Francis Bonnefoy; Stéphanie Lemaire-Ewing; Emmanuel Katsanis; Sylvain Perruche; Philippe Saas; Bernard Bonnotte
Journal:  Biomed Res Int       Date:  2015-09-30       Impact factor: 3.411

Review 10.  Transforming growth factor-beta and matrix metalloproteinases: functional interactions in tumor stroma-infiltrating myeloid cells.

Authors:  Jelena Krstic; Juan F Santibanez
Journal:  ScientificWorldJournal       Date:  2014-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.